Metacrine, Inc.

MTCR · NASDAQ
Analyze with AI
9/30/2022
6/30/2022
3/31/2022
12/31/2021
Revenue$0$0$0$0
% Growth
Cost of Goods Sold$0$0$0$0
Gross Profit$0$0$0$0
% Margin
R&D Expenses$1,322$2,309$6,680$9,177
G&A Expenses$3,842$3,412$5,482$3,910
SG&A Expenses$3,842$3,412$5,482$3,910
Sales & Mktg Exp.$0$0$0$0
Other Operating Expenses-$35-$53$23$0
Operating Expenses$5,164$5,721$12,162$13,087
Operating Income-$5,164-$5,765-$12,512-$13,067
% Margin
Other Income/Exp. Net-$357-$497-$368-$439
Pre-Tax Income-$5,521-$6,262-$12,880-$13,526
Tax Expense-$193$497$368$459
Net Income-$5,328-$6,759-$13,248-$13,985
% Margin
EPS-0.13-0.16-0.31-0.33
% Growth18.8%48.4%6.1%
EPS Diluted-0.13-0.16-0.31-0.33
Weighted Avg Shares Out42,57042,43042,12642,108
Weighted Avg Shares Out Dil42,57042,43042,12642,108
Supplemental Information
Interest Income$228$67$23$17
Interest Expense$550$511$414$459
Depreciation & Amortization$193$58$643-$434
EBITDA-$4,778-$5,707-$11,869-$13,501
% Margin